Reduced Incidence of Invasive Breast Cancer With Raloxifene Among Women at Increased Coronary Risk

BACKGROUND: In the Raloxifene Use for The Heart trial, 10 101 postmenopausal women with coronary heart disease (CHD) or multiple CHD risk factors were randomly assigned to 60 mg/d raloxifene or to placebo and followed for a median of 5.6 years. Raloxifene, a selective estrogen receptor modulator, wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Grady, Deborah, Cauley, Jane A., Geiger, Mary Jane, Kornitzer, Marcel, Mosca, Lori, Collins, Peter, Wenger, Nanette K., Song, Jingli, Mershon, John, Barrett-Connor, Elizabeth
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3559134/
https://ncbi.nlm.nih.gov/pubmed/18544744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn153
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados